SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
How Chronic Inflammation Can Cause Cancer, Ohio State University Study
November 13, 2012
 · 
1 min read
Drug Development
“Calm Down” Genes Treat Epilepsy in Rats, University College London Study
November 13, 2012
 · 
1 min read
Drug Development
It’s Not Just What You Eat, But When You Eat It, University of Pennsylvania Study
November 12, 2012
 · 
1 min read
Drug Development
Social Isolation Disrupts Brain’s “White Matter” Formation, University at Buffalo and Mount Sinai School of Medicine Study
November 12, 2012
 · 
1 min read
Drug Development
Magnet Helps Target Transplanted Iron-Loaded Cells to Key Areas of Heart, INSERM Study
June 29, 2012
 · 
1 min read
Drug Development
Why Eating Fish Boosts Brainpower, University of Alberta Study
June 29, 2012
 · 
1 min read
Drug Development
Combination Therapy Shows Potent Tumor Growth Inhibition in Preclinical Studies, Regeneron Pharmaceuticals, Inc. Reveals
December 2, 2011
 · 
1 min read
Drug Development
Rats on Antidepressants Showed Signs of Autism, University of Mississippi Medical Center Study
October 27, 2011
 · 
1 min read
Drug Development
Experimental Vaccine Protects Monkeys From Blinding Trachoma, National Institute of Allergy And Infectious Diseases (NIAID) Reveals
October 12, 2011
 · 
3 min read
Drug Development
A*STAR Scientists Uncover Critical Link between Inflammation and Cancer
September 28, 2011
 · 
4 min read
Load More
PRESS RELEASES
Drug Development
Humacyte Announces Publication of Preclinical Study Comparing Human Acellular Vessel™ (HAV™) to Expanded Polytetrafluoroethylene (ePTFE) Graft in Vascular Trauma
April 18, 2023
 · 
8 min read
Drug Development
Pre-Clinical Data of Palatin’s Melanocortin Agonist Demonstrating Therapeutic Effects in Diabetic Retinopathy and Uveitis Published in the International Journal of Molecular Sciences
April 18, 2023
 · 
6 min read
Drug Development
Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023
April 18, 2023
 · 
5 min read
Drug Development
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
April 18, 2023
 · 
3 min read
Drug Development
OSE Immunotherapeutics Presents Clinical and Preclinical Data from its Immuno-Oncology Portfolio
April 18, 2023
 · 
11 min read
Drug Development
Monte Rosa Therapeutics Presents Preclinical Data from GSPT1 Degrader Program Focused on MYC-Driven Cancers at AACR 2023
April 17, 2023
 · 
6 min read
Drug Development
Nurix Therapeutics Presents Data at the American Association for Cancer Research (AACR) Annual Meeting Highlighting Activity of its BTK Targeted Protein Degraders, NX-2127 and NX-5948, against a Broad Range of BTKi Resistance Mutations
April 17, 2023
 · 
7 min read
Drug Development
Vincerx Pharma Presents Preclinical Data on Novel Small Molecule Drug Conjugates at the American Association for Cancer Research (AACR) Annual Meeting 2023
April 17, 2023
 · 
7 min read
Drug Development
Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept Data and Highlights a Clinical Case Study in Claudin 18.2-Expressing Cancers at AACR 2023
April 17, 2023
 · 
7 min read
Drug Development
Imvax Presents New Data at AACR 2023 Supporting the Mechanism of Action of its Lead Program, IGV-001, for Glioblastoma
April 17, 2023
 · 
3 min read
Drug Development
Tempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting
April 17, 2023
 · 
6 min read
Drug Development
IN8bio Announces Positive Preclinical Data for Gamma-Delta CAR Platform and Launches New CD33 Program at AACR Annual Meeting 2023
April 17, 2023
 · 
7 min read
Drug Development
Cogent Biosciences Presents Preclinical Data at AACR Annual Meeting Highlighting Precision Therapy Pipeline and Announces Initiation of Part 2 of the Registration-Enabling APEX Trial with Bezuclastinib in Advanced Systemic Mastocytosis
April 17, 2023
 · 
8 min read
Drug Development
Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023
April 17, 2023
 · 
11 min read
Drug Development
Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023
April 17, 2023
 · 
2 min read
Drug Development
Vincerx Pharma Presents Preclinical Data on VIP236, a First-in-Class Small Molecule Drug Conjugate (SMDC), at the 2023 American Association for Cancer Research (AACR) Annual Meeting
April 17, 2023
 · 
7 min read
Drug Development
Sporos BioDiscovery Presents Preclinical Data on Next-Generation TEAD Inhibitor, SPR1-0117, at the American Association for Cancer Research (AACR) Annual Meeting 2023
April 17, 2023
 · 
6 min read
Drug Development
Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Farnesyl Transferase Inhibitor in Combination with Targeted Therapies
April 17, 2023
 · 
6 min read
Drug Development
Preclinical Characterization of Anti-SIRPα mAb BYON4228 Published in Journal for ImmunoTherapy of Cancer
April 17, 2023
 · 
4 min read
Drug Development
Cellectis Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Triple Negative Breast Cancer at the American Association for Cancer Research (AACR) Annual Meeting
April 17, 2023
 · 
5 min read
Load More